Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$57.86 USD
+3.67 (6.77%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $57.82 -0.04 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For KROS
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results